We provide you with 20 years of free, institutional-grade data for GOVX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GOVX. Explore the full financial landscape of GOVX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| DODD DAVID A | Open Market Purchase | 8,000 | $1.95 | 2024-08-12 | |
| DODD DAVID A | Open Market Purchase | 8,729 | $2.15 | 2024-02-22 | |
| Reynolds Mark | Open Market Purchase | 2,000 | $2.77 | 2024-02-07 | |
| McKee Kelly T. Jr. | Open Market Purchase | 6,944 | $0.36 | 2023-12-26 | |
| McKee Kelly T. Jr. | Open Market Purchase | 9,653 | $0.52 | 2023-09-27 | |
| DODD DAVID A | Open Market Purchase | 35,087 | $0.57 | 2023-08-28 | |
| Reynolds Mark | Open Market Purchase | 10,000 | $0.52 | 2023-08-21 | |
| DODD DAVID A | Open Market Purchase | 32,000 | $0.64 | 2023-04-25 | |
| Reynolds Mark | Open Market Purchase | 8,000 | $0.63 | 2023-04-21 | |
| CHASE RANDAL D | Open Market Purchase | 10,000 | $1.1 | 2022-09-23 | |
| Sharkey John W. | Open Market Purchase | 1,000 | $0.82 | 2022-07-05 | |
| McKee Kelly T. Jr. | Open Market Purchase | 4,464 | $1.12 | 2022-06-28 | |
| CHASE RANDAL D | Open Market Purchase | 10,000 | $1.21 | 2022-06-22 | |
| McKee Kelly T. Jr. | Open Market Purchase | 9,722 | $0.72 | 2022-05-06 | |
| McKee Kelly T. Jr. | Open Market Purchase | 4,999 | $0.71 | 2022-05-05 | |
| NEWMAN MARK J | Grant, award...etc | 25,700 | 2021-12-08 | ||
| DODD DAVID A | Open Market Purchase | 163,740 | 2020-09-29 | ||
| Reynolds Mark | Open Market Purchase | 120,368 | 2020-09-29 | ||
| MCNALLY ROBERT T | Open Market Purchase | 107,850 | 2020-09-29 | ||
| SPENCER JOHN N JR | Open Market Purchase | 42,048 | 2020-09-29 | ||
| CHASE RANDAL D | Open Market Purchase | 33,226 | 2020-09-29 | ||
| Kollintzas Dean G | Open Market Purchase | 23,974 | 2020-09-29 | ||
| SPENCER JOHN N JR | Grant, award...etc | 345,000 | 2018-12-19 | ||
| CHASE RANDAL D | Grant, award...etc | 320,000 | 2018-12-19 | ||
| MCNALLY ROBERT T | Grant, award...etc | 650,000 | 2018-12-19 | ||
| Kollintzas Dean G | Grant, award...etc | 300,000 | 2018-12-19 | ||
| ROBINSON HARRIET L | Grant, award...etc | 600,000 | 2018-12-19 | ||
| DODD DAVID A | Grant, award...etc | 785,000 | 2018-12-19 | ||
| Guirakhoo Farshad | Grant, award...etc | 625,000 | 2018-12-19 | ||
| Reynolds Mark | Grant, award...etc | 750,000 | 2018-12-19 | ||
| Kollintzas Dean G | Grant, award...etc | 170,000 | 2017-12-22 | ||
| SPENCER JOHN N JR | Grant, award...etc | 240,000 | 2017-12-22 | ||
| CHASE RANDAL D | Grant, award...etc | 200,000 | 2017-12-22 | ||
| ROBINSON HARRIET L | Grant, award...etc | 450,000 | 2017-12-22 | ||
| DODD DAVID A | Grant, award...etc | 270,000 | 2017-12-22 | ||
| Guirakhoo Farshad | Grant, award...etc | 500,000 | 2017-12-22 | ||
| MCNALLY ROBERT T | Grant, award...etc | 750,000 | 2017-12-22 | ||
| Reynolds Mark | Grant, award...etc | 750,000 | 2017-12-22 | ||
| MCNALLY ROBERT T | Grant, award...etc | 462,500 | 2016-12-15 | ||
| Guirakhoo Farshad | Grant, award...etc | 170,000 | 2016-12-15 | ||
| Reynolds Mark | Grant, award...etc | 335,000 | 2016-12-15 | ||
| CHASE RANDAL D | Grant, award...etc | 106,700 | 2016-12-15 | ||
| Kollintzas Dean G | Grant, award...etc | 79,275 | 2016-12-15 | ||
| ROBINSON HARRIET L | Grant, award...etc | 262,200 | 2016-12-15 | ||
| DODD DAVID A | Grant, award...etc | 202,800 | 2016-12-15 | ||
| SPENCER JOHN N JR | Grant, award...etc | 123,500 | 2016-12-15 |
The information provided in this report about GOVX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
GeoVax Labs, Inc(NASDAQ:GOVX) 
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against coronavirus (COVID-19), human immun...
Website: http://www.geovax.com
Founded: 1988
Full Time Employees: 6
CEO: David A. Dodd
Sector: Healthcare
Industry: Biotechnology